- Correction
- Open Access
- Published:
Correction to: Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism
Journal of Ovarian Research volume 14, Article number: 105 (2021)
Correction to: J Ovarian Res 14, 97 (2021)
In the original publication of this article [1], the legend for Figs. 1 and 2 were missing. The correct figures are shown here. The original article has been corrected.
ROC curve analysis of SFRP5 for total PCOS. In all PCOS population, the SFRP5 cut-off value was 46.13 ng/ml (AUC 0.960; 95% CI 0.900–0.989; P < 0.0001) to identify PCOS with a sensitivity of 88.06% and specificity of 96.87%. The AMH cut-off value was 3.23 ng/ml (AUC 0.968; 95% CI 0.912–0.993; P < 0.0001) with a sensitivity of 98.51% and specificity of 90.62%. The AUC of combination of SFRP5 and AMH was 0.980 with a sensitivity of 91.04% and specificity of 100% (95% CI 0.930–0.998; P < 0.0001). AUC: area under the curve, ROC: receiver operating characteristic analysis
ROC curve analysis of SFRP5 for PCOS with AMH < 4.7 ng/ml. In PCOS with AMH < 4.7 ng/ml, the SFRP5 cut-off value was 42.69 ng/ml (AUC, 0.955; 95% CI 0.864–0.992; P < 0.0001) to identify PCOS with a sensitivity of 82.61% and specificity of 96.97%. AUC: area under the curve, ROC: receiver operating characteristic analysis
Reference
Zhang Y, Ran Y, Kong L, et al. Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism. J Ovarian Res. 2021;14:97. https://doi.org/10.1186/s13048-021-00847-4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, Y., Ran, Y., Kong, L. et al. Correction to: Decreased SFRP5 correlated with excessive metabolic inflammation in polycystic ovary syndrome could be reversed by metformin: implication of its role in dysregulated metabolism. J Ovarian Res 14, 105 (2021). https://doi.org/10.1186/s13048-021-00855-4
Published:
DOI: https://doi.org/10.1186/s13048-021-00855-4